These functional experiments provide strong evidence that BOP1, CTBP1, DSE, PMSD10, and SRPK1 play key roles in LMS progression, acting as potential therapeutic targets to limit tumor invasion and metastasis. Here, SRPK1 is linked to neoplasm.